Showing results (71-80 of 503) with videos related to
Sort By:
Pageof 51
Journal of Medical Genetics|December 1, 1991
Selection in blood cells from female carriers of the fragile X syndrome: inverse correlation between age and proportion of active X chromosomes carrying the full mutationF Rousseau, D Heitz, I Oberlé, et al.Journal of Diabetes and Its Complications|December 21, 2013
Parental brevity linked to cardiometabolic risk in diabetic descendantsMichel P Hermans, Sylvie A Ahn, Michel F RousseauFrontiers in Medicine|June 19, 2018
Cell and Gene Therapies: European View on Challenges in Translation and How to Address ThemCécile F Rousseau, Romaldas Mačiulaitis, Dariusz Śladowski, et al.British Journal of Clinical Pharmacology|January 1, 1989
Focus on diastolic dysfunction: a new approach to heart failure therapyH Pouleur, C Hanet, O Gurné, et al.Revue Medicale De Liege|September 9, 2022
[Phage therapy, an additional strategy against multidrug-resistant bacteria]M Boniver, P Wotquenne, M Moutschen, et al.Journal of Diabetes and Its Complications|April 24, 2012
The multi-faceted outcomes of conjunct diabetes and cardiovascular familial history in type 2 diabetesMichel P Hermans, Sylvie A Ahn, Michel F RousseauDiabetes & Vascular Disease Research|April 7, 2010
Raised natriuretic peptides, big-endothelin-1 and improved beta-cell function in type 2 diabetic males with hyperuricaemiaMichel P Hermans, Sylvie A Ahn, Michel F RousseauCardiovascular Diabetology|March 1, 2013
Discriminant ratio and biometrical equivalence of measured vs. calculated apolipoprotein B100 in patients with T2DMMichel P Hermans, Sylvie A Ahn, Michel F RousseauLipids in Health and Disease|October 11, 2012
The atherogenic dyslipidemia ratio [log(TG)/HDL-C] is associated with residual vascular risk, beta-cell function loss and microangiopathy in type 2 diabetes femalesMichel P Hermans, Sylvie A Ahn, Michel F RousseauCardiovascular Diabetology|December 16, 2010
log(TG)/HDL-C is related to both residual cardiometabolic risk and β-cell function loss in type 2 diabetes malesMichel P Hermans, Sylvie A Ahn, Michel F RousseauPageof 51